FDA cleared the Arctic Sun™ Neonatal ArcticGel™ Pad from Medivance, Inc. on Oct 30, 2026 under K263587, a special 510(k). The device falls under product code DWJ, System, Thermal Regulating, regulated at 21 CFR 870.5900 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Sep 30, 2026. The decision came 30 days later, inside the 90 FDA-day goal for a 510(k).

This is the only decision on file for Medivance, Inc. in the last 12 months of the tracker.